These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2125 related articles for article (PubMed ID: 8400856)

  • 21. [Anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Wei Y; Kan B
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):118-21. PubMed ID: 11783014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
    Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
    Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant angioarrestin secreted from mouse melanoma cells inhibits growth of primary tumours.
    Smagur A; Szary J; Szala S
    Acta Biochim Pol; 2005; 52(4):875-9. PubMed ID: 15940350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for subchoroidal implantation of Greene melanoma in rabbits.
    Shikishima K
    Int J Clin Oncol; 2004 Apr; 9(2):79-84. PubMed ID: 15108038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
    Kayaga J; Souberbielle BE; Sheikh N; Morrow WJ; Scott-Taylor T; Vile R; Chong H; Dalgleish AG
    Gene Ther; 1999 Aug; 6(8):1475-81. PubMed ID: 10467372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
    Yi C; Huang Y; Guo ZY; Wang SR
    Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
    Drewa G; Woźqak A; Pałgan K; Schachtschabel DO; Grzanka A; Sujkowska R
    Neoplasma; 2001; 48(1):12-8. PubMed ID: 11327532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
    Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
    Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro].
    Liu DY; Zheng HQ; Luo GQ
    Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):957-61. PubMed ID: 15620188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transplantation of melanoblastoma of the human eye into the anterior chamber].
    Nifontova TP
    Vopr Onkol; 1976; 22(6):92-4. PubMed ID: 969351
    [No Abstract]   [Full Text] [Related]  

  • 33. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
    Baldini PM; Lentini A; Mattioli P; Provenzano B; De Vito P; Vismara D; Beninati S
    Melanoma Res; 2006 Dec; 16(6):501-7. PubMed ID: 17119451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain.
    Kuratomi Y; Nomizu M; Nielsen PK; Tanaka K; Song SY; Kleinman HK; Yamada Y
    Exp Cell Res; 1999 Jun; 249(2):386-95. PubMed ID: 10366438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma growth and tumorigenicity in models of microgravity.
    Taga M; Yamauchi K; Odle J; Furian L; Sundaresan A; Ramesh GT; Pellis NR; Andrassy RJ; Kulkarni AD
    Aviat Space Environ Med; 2006 Nov; 77(11):1113-6. PubMed ID: 17086762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental model of malignant neoplasm of the eye].
    Sporny S
    Patol Pol; 1988; 39(2):104-13. PubMed ID: 3251180
    [No Abstract]   [Full Text] [Related]  

  • 38. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors.
    Apte RS; Mayhew E; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1277-82. PubMed ID: 9152248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reproducible model of metastatic brain and ocular tumor by hematogenous inoculation of the VX2 tumor in rabbits.
    Frank JA; Girton M; Dwyer AJ; Cohen PJ; Knop RH; Diggs R; Cobb J; Doppman JL
    J Neurosurg; 1987 Jul; 67(1):106-9. PubMed ID: 3598658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autografting and allografting of bovine ocular squamous cell carcinoma.
    Hoffmann D; Jennings PA; Spradbrow PB; Wilson BE
    Res Vet Sci; 1981 Jul; 31(1):48-53. PubMed ID: 7313318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 107.